Registration for PeproTech.com is no longer available. To order your PeproTech products online, register or logon to ThermoFisher.com.

Resources & Support

References

First Author
Sanderson, N S
Title
Cytotoxic immunological synapses do not restrict the action of interferon-γ to antigenic target cells.
Citation
Proceedings of the National Academy of Sciences of the United States of America; 2012 May 15; 109(20) pg7835-40
PubMed ID
22547816
Show Usages
Product Cited
Cross-Reactivity
Applications
500-P32
Human
Immunostaining
First Author
Moschen, A R
Title
Interferon-alpha controls IL-17 expression in vitro and in vivo.
Citation
Immunobiology; 2008; 213(9-10) pg779-87
PubMed ID
18926293
Show Usages
Product Cited
Cross-Reactivity
Applications
500-P32
Human
in vitro
200-01B
Human
in vitro
200-02
Human
in vitro
200-06
Human
in vitro
First Author
Bradshaw, E M
Title
Concurrent detection of secreted products from human lymphocytes by microengraving: cytokines and antigen-reactive antibodies.
Citation
Clinical immunology (Orlando, Fla.); 2008 Oct; 129(1) pg10-8
PubMed ID
18675591
Show Usages
Product Cited
Cross-Reactivity
Applications
500-P32
Human
in vitro
200-06
Human
in vitro
300-02
Human
in vitro
500-P26
Human
in vitro
First Author
Takagi, R
Title
B cell chemoattractant CXCL13 is preferentially expressed by human Th17 cell clones.
Citation
Journal of immunology (Baltimore, Md. : 1950); 2008 Jul 1; 181(1) pg186-9
PubMed ID
18566383
Show Usages
Product Cited
Cross-Reactivity
Applications
100-21
Human
in vitro
500-P32
Human
in vitro
200-01B
Human
in vitro
200-06
Human
in vitro
200-12
Human
in vitro
300-01A
Human
in vitro
500-P24
Human
in vitro
First Author
Chiu, W K
Title
Generation and growth of CD28nullCD8+ memory T cells mediated by IL-15 and its induced cytokines.
Citation
Journal of immunology (Baltimore, Md. : 1950); 2006 Dec 1; 177(11) pg7802-10
PubMed ID
17114451
Show Usages
Product Cited
Cross-Reactivity
Applications
500-P13
Human
Neutralization
500-P28
Human
Neutralization
500-P32
Human
Neutralization
200-15
Human
Neutralization
300-01A
Human
Neutralization
300-09
Human
Neutralization
500-P25
Human
Neutralization
500-P26
Human
Neutralization
500-P33
Human
Neutralization
500-P38B
Human
Neutralization
200-15
Human
in vitro
300-01A
Human
in vitro
300-09
Human
in vitro
500-P25
Human
in vitro
500-P26
Human
in vitro
500-P33
Human
in vitro
500-P13
Human
in vitro
500-P28
Human
in vitro
500-P32
Human
in vitro
500-P38B
Human
in vitro
First Author
Lin, C
Title
Immunization with Epstein-Barr Virus (EBV) peptide-pulsed dendritic cells induces functional CD8+ T-cell immunity and may lead to tumor regression in patients with EBV-positive nasopharyngeal carcinoma.
Citation
Cancer Research; 2002 Dec 1; 62(23) pg6952-8
PubMed ID
12460912
Show Usages
Product Cited
Cross-Reactivity
Applications
500-P32
Human
Flow cytometry
First Author
Little, C H
Title
Measurement of T-cell-derived antigen binding molecules and immunoglobulin G specific to Candida albicans mannan in sera of patients with recurrent vulvovaginal candidiasis.
Citation
Infection and Immunity; 2000 Jul; 68(7) pg3840-7
PubMed ID
10858192
Show Usages
Product Cited
Cross-Reactivity
Applications
500-P32
Human
ELISA
First Author
O'Neil, D
Title
IFN-gamma down-regulates MHC expression and antigen processing in a human B cell line.
Citation
Journal of immunology (Baltimore, Md. : 1950); 1999 Jan 15; 162(2) pg791-8
PubMed ID
9916700
Show Usages
Product Cited
Cross-Reactivity
Applications
500-P32
Human
Neutralization
First Author
Takeichi, O
Title
Cytokine regulation on the synthesis of nitric oxide in vivo by chronically infected human polymorphonuclear leucocytes.
Citation
Immunology; 1998 Feb; 93(2) pg275-80
PubMed ID
9616379
Show Usages
Product Cited
Cross-Reactivity
Applications
500-P32
Human
Neutralization
showing 9 of 9